Edition:
United Kingdom

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.81USD
17 Jul 2018
Change (% chg)

-- (--)
Prev Close
$1.81
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,457
52-wk High
$3.91
52-wk Low
$1.58

Chart for

About

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action,... (more)
No analyst recommendations are available for .

Overall

Beta: -0.08
Market Cap(Mil.): $13.38
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  XTLB.OQ Industry Sector
P/E (TTM): -- 85.48 32.76
EPS (TTM): -1.00 -- --
ROI: -70.95 2.29 14.61
ROE: -125.01 3.86 16.34

Earnings vs. Estimates